Dow Down 1.60% Nasdaq Down 0.39%

Heat Biologics, Inc. (HTBX)

-NasdaqCM
2.13 Down 0.08(3.61%) Feb 11, 3:58PM EST
Prev Close:2.21
Open:2.21
Bid:2.11 x 500
Ask:2.16 x 300
1y Target Est:15.67
Beta:0.947747
Next Earnings Date:N/A
Day's Range:2.13 - 2.37
52wk Range:1.67 - 10.90
Volume:20,665
Avg Vol (3m):82,653
Market Cap:17.95M
P/E (ttm):N/A
EPS (ttm):-2.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HTBX

Comparison

Symbol% ChgMkt Cap
HTBXDown 3.61%17.95M
IMGNUp 1.00%617.26M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.40
Quarterly EPS Est (Dec-15) :-0.64
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Heat Biologics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback